| Nanogels as drug carriers–Introduction, chemical aspects, release mechanisms and potential applications S Shah, N Rangaraj, K Laxmikeshav, S Sampathi International journal of pharmaceutics 581, 119268, 2020 | 107 | 2020 |
| Lipid polymer hybrid nanocarriers: Insights into synthesis aspects, characterization, release mechanisms, surface functionalization and potential implications S Shah, P Famta, RS Raghuvanshi, SB Singh, S Srivastava Colloid and Interface Science Communications 46, 100570, 2022 | 74 | 2022 |
| Lipid based nanocarriers: A novel paradigm for topical antifungal therapy S Nene, S Shah, N Rangaraj, NK Mehra, PK Singh, S Srivastava Journal of Drug Delivery Science and Technology 62, 102397, 2021 | 55 | 2021 |
| QbD aided development of ibrutinib-loaded nanostructured lipid carriers aimed for lymphatic targeting: evaluation using chylomicron flow blocking approach N Rangaraj, SR Pailla, S Shah, S Prajapati, S Sampathi Drug delivery and translational research 10, 1476-1494, 2020 | 52 | 2020 |
| Exploring new Horizons in overcoming P-glycoprotein-mediated multidrug-resistant breast cancer via nanoscale drug delivery platforms P Famta, S Shah, E Chatterjee, H Singh, B Dey, SK Guru, SB Singh, ... Current Research in Pharmacology and Drug Discovery 2, 100054, 2021 | 47 | 2021 |
| Nanotechnological advances for nose to brain delivery of therapeutics to improve the Parkinson therapy DK Khatri, K Preeti, S Tonape, S Bhattacharjee, M Patel, S Shah, ... Current neuropharmacology 21 (3), 493-516, 2023 | 38 | 2023 |
| Albumin-hitchhiking: fostering the pharmacokinetics and anticancer therapeutics P Famta, S Shah, N Jain, DA Srinivasarao, A Murthy, T Ahmed, ... Journal of Controlled Release 353, 166-185, 2023 | 37 | 2023 |
| Bridging the gap: academia, industry and FDA convergence for nanomaterials S Shah, S Nene, N Rangaraj, RS Raghuvanshi, SB Singh, S Srivastava Drug development and industrial pharmacy 46 (11), 1735-1746, 2020 | 35 | 2020 |
| Nanotechnology based drug delivery systems: Does shape really matter? S Shah, P Famta, D Bagasariya, K Charankumar, E Amulya, DK Khatri, ... International Journal of Pharmaceutics 625, 122101, 2022 | 33 | 2022 |
| Advancements in redox-sensitive micelles as nanotheranostics: a new horizon in cancer management A Sikder, G Vambhurkar, E Amulya, D Bagasariya, P Famta, S Shah, ... Journal of Controlled Release 349, 1009-1030, 2022 | 32 | 2022 |
| Quality by design steered development of Niclosamide loaded liposomal thermogel for Melanoma: In vitro and Ex vivo evaluation S Shah, P Famta, V Fernandes, D Bagasariya, K Charankumar, DK Khatri, ... European journal of pharmaceutics and biopharmaceutics 180, 119-136, 2022 | 29 | 2022 |
| Quality by design (QbD) assisted Fabrication & evaluation of Simvastatin loaded Nano-Enabled thermogel for melanoma therapy P Famta, S Shah, V Fernandes, KC Kumar, D Bagasariya, KS Samim, ... International journal of pharmaceutics 628, 122270, 2022 | 28 | 2022 |
| Nanomedicine based approaches for combating viral infections S Shah, MB Chougule, AK Kotha, R Kashikar, C Godugu, ... Journal of Controlled Release 338, 80-104, 2021 | 28 | 2021 |
| Enigmatic role of exosomes in breast cancer progression and therapy P Famta, S Shah, DK Khatri, SK Guru, SB Singh, S Srivastava Life Sciences 289, 120210, 2022 | 27 | 2022 |
| Quality by design approach for the development of self-emulsifying systems for oral delivery of febuxostat: pharmacokinetic and pharmacodynamic evaluation N Rangaraj, S Shah, M AJ, SR Pailla, HS Cheruvu, S Sampathi AAPS PharmSciTech 20 (7), 267, 2019 | 26 | 2019 |
| Tuning mesoporous silica nanoparticles in novel avenues of cancer therapy S Shah, P Famta, D Bagasariya, K Charankumar, A Sikder, R Kashikar, ... Molecular Pharmaceutics 19 (12), 4428-4452, 2022 | 25 | 2022 |
| Tumor-promoting aftermath post-chemotherapy: a focus on breast cancer P Famta, S Shah, N Jain, KC Kumar, D Bagasariya, DK Khatri, ... Life sciences 310, 121125, 2022 | 22 | 2022 |
| Exploring the unexplored avenues of surface charge in nano-medicine S Shah, N Rangaraj, SB Singh, S Srivastava Colloid and Interface Science Communications 42, 100406, 2021 | 22 | 2021 |
| Quality by design (QbD) abetted development of pioglitazone incorporated liposomes-loaded hyaluronic acid-based in situ hydrogel for the management of melanoma K Charankumar, D Bagasariya, N Jain, P Famta, S Shah, G Vambhurkar, ... Journal of drug delivery science and technology 84, 104453, 2023 | 20 | 2023 |
| Nanomedicine based strategies for oligonucleotide traversion across the blood–brain barrier E Amulya, A Sikder, G Vambhurkar, S Shah, DK Khatri, RS Raghuvanshi, ... Journal of Controlled Release 354, 554-571, 2023 | 20 | 2023 |
